Literature DB >> 35107701

Description of Pseudoclavibacter triregionum sp. nov. from human blood and Pseudoclavibacter albus comb. nov., and revised classification of the genus Pseudoclavibacter: proposal of Caespitibacter gen. nov., with Caespitibacter soli comb. nov. and Caespitibacter caeni comb. nov.

Peter Vandamme1, Charlotte Peeters2, Helena M B Seth-Smith3,4, Hanna Schmid5, Margo Cnockaert2, Adrian Egli3,4, Daniel Goldenberger4.   

Abstract

We present polyphasic taxonomic data to demonstrate that strain 125703-2019T, a human blood isolate, represents a novel species within the genus Pseudoclavibacter, and to reclassify the illegitimate Zimmermannella alba Lin et al., 2004 as Pseudoclavibacter albus comb. nov. Upon primary isolation, strain 125703-2019T could not be identified reliably using MALDI-TOF mass spectrometry during routine diagnostic work, but partial 16S rRNA gene sequence analysis revealed that it belonged to the genus Pseudoclavibacter. Average nucleotide identity and digital DNA-DNA hybridisation analyses confirmed that it represented a novel species within this genus. A detailed physiological characterisation yielded differential tests between the novel species and its nearest neighbor taxa, which could also be differentiated using MALDI-TOF mass spectrometry. We propose to formally classify this strain into the novel species Pseudoclavibacter triregionum sp. nov., with strain 125703-2019T (= R-76471T, LMG 31777T, CCUG 74796T) as the type strain. The whole-genome assembly of strain 125703-2019T has a size of 2.4 Mb and a G + C content of 72.74%. A Pseudoclavibacter pangenome analysis revealed that 667 gene clusters were exclusively present in strain 125703-2019T. While these gene clusters were enriched in several COG functional categories, this analysis did not reveal functions that explained the occurrence of this species in human infection. Finally, several phylogenetic and phylogenomic analyses demonstrated that the genus Pseudoclavibacter is polyphyletic with Pseudoclavibacter soli and Pseudoclavibacter caeni representing a unique and deeply branching line of descent within the family Microbacteriaceae. We therefore also propose to reclassify both species into the novel genus Caespitibacter gen. nov. as Caespitibacter soli comb. nov. and Caespitibacter caeni comb. nov., respectively, and with C. soli comb. nov. as the type species.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Caespitibacter; Human clinical sample; Human microbiome; Pseudoclavibacter; Whole genome sequence; Zimmermannella alba

Mesh:

Substances:

Year:  2022        PMID: 35107701     DOI: 10.1007/s10482-022-01712-0

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  27 in total

1.  Pseudoclavibacter terrae sp. nov. isolated from rhizosphere soil of Ophiopogon japonicus.

Authors:  Juan Du; Hina Singh; Jung-Eun Yang; Chang Shik Yin; MooChang Kook; Hongshan Yu; Tae-Hoo Yi
Journal:  Int J Syst Evol Microbiol       Date:  2015-08-25       Impact factor: 2.747

2.  Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates.

Authors:  Michael Feldgarden; Vyacheslav Brover; Daniel H Haft; Arjun B Prasad; Douglas J Slotta; Igor Tolstoy; Gregory H Tyson; Shaohua Zhao; Chih-Hao Hsu; Patrick F McDermott; Daniel A Tadesse; Cesar Morales; Mustafa Simmons; Glenn Tillman; Jamie Wasilenko; Jason P Folster; William Klimke
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  bcgTree: automatized phylogenetic tree building from bacterial core genomes.

Authors:  Markus J Ankenbrand; Alexander Keller
Journal:  Genome       Date:  2016-05-11       Impact factor: 2.166

4.  "Dark" Purkinje cells of the cerebellar cortex.

Authors:  C Léránth; J Hámori
Journal:  Acta Biol Acad Sci Hung       Date:  1970

5.  COG database update: focus on microbial diversity, model organisms, and widespread pathogens.

Authors:  Michael Y Galperin; Yuri I Wolf; Kira S Makarova; Roberto Vera Alvarez; David Landsman; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2020-11-09       Impact factor: 16.971

Review 6.  Microbial genome analysis: the COG approach.

Authors:  Michael Y Galperin; David M Kristensen; Kira S Makarova; Yuri I Wolf; Eugene V Koonin
Journal:  Brief Bioinform       Date:  2019-07-19       Impact factor: 11.622

7.  Pseudoclavibacter soli sp. nov., a {beta}-glucosidase-producing bacterium.

Authors:  Myung Kyum Kim; Hee-Young Jung
Journal:  Int J Syst Evol Microbiol       Date:  2009-04       Impact factor: 2.747

8.  Pseudoclavibacter chungangensis sp. nov., isolated from activated sludge.

Authors:  Sung-Lim Cho; Min Young Jung; Mi-Hak Park; Young-Hyo Chang; Jung-Hoon Yoon; Soon Chul Myung; Wonyong Kim
Journal:  Int J Syst Evol Microbiol       Date:  2009-09-04       Impact factor: 2.747

9.  Community-led, integrated, reproducible multi-omics with anvi'o.

Authors:  A Murat Eren; Evan Kiefl; Alon Shaiber; Iva Veseli; Samuel E Miller; Matthew S Schechter; Isaac Fink; Jessica N Pan; Mahmoud Yousef; Emily C Fogarty; Florian Trigodet; Andrea R Watson; Özcan C Esen; Ryan M Moore; Quentin Clayssen; Michael D Lee; Veronika Kivenson; Elaina D Graham; Bryan D Merrill; Antti Karkman; Daniel Blankenberg; John M Eppley; Andreas Sjödin; Jarrod J Scott; Xabier Vázquez-Campos; Luke J McKay; Elizabeth A McDaniel; Sarah L R Stevens; Rika E Anderson; Jessika Fuessel; Antonio Fernandez-Guerra; Lois Maignien; Tom O Delmont; Amy D Willis
Journal:  Nat Microbiol       Date:  2021-01       Impact factor: 17.745

10.  eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses.

Authors:  Jaime Huerta-Cepas; Damian Szklarczyk; Davide Heller; Ana Hernández-Plaza; Sofia K Forslund; Helen Cook; Daniel R Mende; Ivica Letunic; Thomas Rattei; Lars J Jensen; Christian von Mering; Peer Bork
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.